Knockdown of circ-PIP5K1A overcomes resistance to cisplatin in ovarian cancer by miR-942-5p/NFIB axis. Sheng H, Wang X. Anticancer Drugs 2022 Nov 16. doi: 10.1097/CAD.0000000000001406.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sheng H, Wang X. Knockdown of circ-PIP5K1A overcomes resistance to cisplatin in ovarian cancer by miR-942-5p/NFIB axis. Anticancer Drugs 2022 Nov 16. doi: 10.1097/CAD.0000000000001406.
PMID: 36730637